BSE Prices delayed by 5 minutes... << Prices as on Jun 30, 2025 - 11:51AM >>   ABB  6099.45 ATS - Market Arrow  [0.49]  ACC  1918.2 ATS - Market Arrow  [-0.17]  AMBUJA CEM  575.55 ATS - Market Arrow  [0.06]  ASIAN PAINTS  2344.6 ATS - Market Arrow  [-0.62]  AXIS BANK  1213.8 ATS - Market Arrow  [-0.93]  BAJAJ AUTO  8474.45 ATS - Market Arrow  [0.38]  BANKOFBARODA  248.45 ATS - Market Arrow  [2.94]  BHARTI AIRTE  2006.35 ATS - Market Arrow  [-1.06]  BHEL  266.7 ATS - Market Arrow  [1.00]  BPCL  335.15 ATS - Market Arrow  [0.63]  BRITANIAINDS  5804 ATS - Market Arrow  [0.20]  CIPLA  1502.2 ATS - Market Arrow  [-0.04]  COAL INDIA  393 ATS - Market Arrow  [-0.46]  COLGATEPALMO  2407.35 ATS - Market Arrow  [1.10]  DABUR INDIA  481.6 ATS - Market Arrow  [-0.88]  DLF  840.75 ATS - Market Arrow  [-0.60]  DRREDDYSLAB  1279.05 ATS - Market Arrow  [-1.70]  GAIL  190.35 ATS - Market Arrow  [-0.31]  GRASIM INDS  2858.9 ATS - Market Arrow  [-0.21]  HCLTECHNOLOG  1722.75 ATS - Market Arrow  [-0.14]  HDFC BANK  1997.9 ATS - Market Arrow  [-0.82]  HEROMOTOCORP  4265.5 ATS - Market Arrow  [-1.28]  HIND.UNILEV  2310.95 ATS - Market Arrow  [0.21]  HINDALCO  695 ATS - Market Arrow  [-0.37]  ICICI BANK  1449.6 ATS - Market Arrow  [-0.83]  INDIANHOTELS  761.1 ATS - Market Arrow  [-0.86]  INDUSINDBANK  869.65 ATS - Market Arrow  [1.39]  INFOSYS  1604.4 ATS - Market Arrow  [-0.26]  ITC LTD  418.4 ATS - Market Arrow  [-0.13]  JINDALSTLPOW  946.8 ATS - Market Arrow  [0.80]  KOTAK BANK  2179.5 ATS - Market Arrow  [-1.29]  L&T  3687.5 ATS - Market Arrow  [0.24]  LUPIN  1932.3 ATS - Market Arrow  [-0.24]  MAH&MAH  3188.1 ATS - Market Arrow  [-0.54]  MARUTI SUZUK  12497 ATS - Market Arrow  [-1.17]  MTNL  52.23 ATS - Market Arrow  [0.56]  NESTLE  2455.1 ATS - Market Arrow  [-0.11]  NIIT  130.35 ATS - Market Arrow  [-0.72]  NMDC  70.4 ATS - Market Arrow  [0.67]  NTPC  335.2 ATS - Market Arrow  [-0.81]  ONGC  243.65 ATS - Market Arrow  [0.31]  PNB  109.5 ATS - Market Arrow  [2.96]  POWER GRID  299 ATS - Market Arrow  [-0.20]  RIL  1514 ATS - Market Arrow  [-0.14]  SBI  819.35 ATS - Market Arrow  [1.73]  SESA GOA  461.6 ATS - Market Arrow  [-0.53]  SHIPPINGCORP  224.7 ATS - Market Arrow  [-1.01]  SUNPHRMINDS  1702.35 ATS - Market Arrow  [0.85]  TATA CHEM  939 ATS - Market Arrow  [0.55]  TATA GLOBAL  1099.6 ATS - Market Arrow  [-2.07]  TATA MOTORS  688.95 ATS - Market Arrow  [0.33]  TATA STEEL  160.9 ATS - Market Arrow  [-0.31]  TATAPOWERCOM  405.75 ATS - Market Arrow  [-0.75]  TCS  3454.4 ATS - Market Arrow  [0.33]  TECH MAHINDR  1670.55 ATS - Market Arrow  [-0.27]  ULTRATECHCEM  12094 ATS - Market Arrow  [-1.15]  UNITED SPIRI  1429.5 ATS - Market Arrow  [-0.91]  WIPRO  265.15 ATS - Market Arrow  [0.04]  ZEETELEFILMS  147.2 ATS - Market Arrow  [2.05]  

Ajanta Pharma Ltd.

Auditor Report

NSE: AJANTPHARMEQ BSE: 532331ISIN: INE031B01049INDUSTRY: Pharmaceuticals

BSE   Rs 2556.30   Open: 2531.30   Today's Range 2531.30
2586.45
 
NSE
Rs 2555.00
+34.30 (+ 1.34 %)
+31.35 (+ 1.23 %) Prev Close: 2524.95 52 Week Range 2022.05
3485.75
You can view full text of the latest Auditor's Report for the company.
Market Cap. (Rs.) 31915.04 Cr. P/BV 8.68 Book Value (Rs.) 294.36
52 Week High/Low (Rs.) 3485/2160 FV/ML 2/1 P/E(X) 34.68
Bookclosure 06/11/2024 EPS (Rs.) 73.68 Div Yield (%) 1.10
Year End :2025-03 

Key audit matter

See Note 6.9, 35 and 50 to standalone financial statements

The key audit matter

How the matter was addressed in our audit

Revenue from sale of products is recognised at a point in time
when control of the products is transferred to the customer.
The actual point in time when revenue is recognised varies
depending on the specific terms and conditions of the sales
contracts entered with customers. Revenue from the sale of
goods is measured based on the transaction price adjusted
for discounts and rebates, which is specified in contract with
customers. The Company has many customers operating in
various geographies and sales contracts with these customers
have distinct terms and conditions relating to the recognition
of revenue and right of return.

We identified the recognition of revenue from sale of products
as a key audit matter considering:

Revenue is a key performance indicator for the Company.
Accordingly, there could be pressure to meet the expectations
of investors / other stakeholders and / or to meet revenue
targets stipulated in performance incentive schemes for a
reporting period. We have considered that there is a risk of
fraud related to revenue being overstated by recognition in the
wrong period or before control has passed during the year and
at period end.

Our procedures in respect of recognition of revenue included the

following:

» Verifying the accounting policies adopted by the Company
with respect to recognition of revenue by comparing with the
applicable accounting standards.

» Testing the design, implementation and operating
effectiveness of the Company's manual and automated
controls over revenue recognition.

» Performing substantive testing of selected samples of revenue
transactions recorded during the year as well as at year-
end. We used statistical sampling and verified contractual
terms of sales invoices / contracts, shipping documents and
acknowledged delivery receipts for those transactions.

» Analysing and testing high risk journal entries that contain
unusual combinations of credit to revenue with no associated
debit to cash, debtors or another revenue account.

» We assessed the adequacy of the disclosures made in the
financial statements as per the requirement of Ind AS 115
Revenue from contracts with customers.

We have audited the standalone financial statements
of Ajanta Pharma Limited (the “Company") which
comprise the standalone balance sheet as at 31
March 2025, and the standalone statement of profit
and loss (including other comprehensive income),
standalone statement of changes in equity and
standalone statement of cash flows for the year
then ended, and notes to the standalone financial
statements, including material accounting policies and
other explanatory information.

In our opinion and to the best of our information
and according to the explanations given to us, the
aforesaid standalone financial statements give the
information required by the Companies Act, 2013
(“Act") in the manner so required and give a true and
fair view in conformity with the accounting principles
generally accepted in India, of the state of affairs of
the Company as at 31 March 2025, and its profit and
other comprehensive loss, changes in equity and its
cash flows for the year ended on that date.

Basis for Opinion

We conducted our audit in accordance with the
Standards on Auditing (SAs) specified under Section
143(10) of the Act. Our responsibilities under those SAs
are further described in the Auditor's Responsibilities
for the Audit of the Standalone Financial Statements
section of our report. We are independent of the
Company in accordance with the Code of Ethics
issued by the Institute of Chartered Accountants
of India together with the ethical requirements that
are relevant to our audit of the standalone financial
statements under the provisions of the Act and the
Rules thereunder, and we have fulfilled our other
ethical responsibilities in accordance with these
requirements and the Code of Ethics. We believe that
the audit evidence we have obtained is sufficient and
appropriate to provide a basis for our opinion on the
standalone financial statements.

Key Audit Matter

Key audit matters are those matters that, in our
professional judgement were of most significance in
our audit of the standalone financial statements of
the current period. These matters were addressed in
the context of our audit of the standalone financial
statements as a whole, and in forming our opinion
thereon, and we do not provide a separate opinion
on these matters.

Other Information

The Company's Management and Board of Directors
are responsible for the other information. The other
information comprises the information included in the
Company's annual report, but does not include the
financial statements and auditor's report thereon.

Our opinion on the standalone financial statements
does not cover the other information and we do not
express any form of assurance conclusion thereon.

In connection with our audit of the standalone
financial statements, our responsibility is to read the
other information and, in doing so, consider whether
the other information is materially inconsistent with
the standalone financial statements or our knowledge
obtained in the audit or otherwise appears to be
materially misstated. If, based on the work we have
performed, we conclude that there is a material
misstatement of this other information, we are required
to report that fact. We have nothing to report in
this regard.

Management's and Board of Directors'
Responsibilities for the Standalone Financial
Statements

The Company's Management and Board of Directors
are responsible for the matters stated in Section
134(5) of the Act with respect to the preparation of
these standalone financial statements that give a
true and fair view of the state of affairs, profit/ loss
and other comprehensive income, changes in equity
and cash flows of the Company in accordance with
the accounting principles generally accepted in
India, including the Indian Accounting Standards
(Ind AS) specified under Section 133 of the Act. This
responsibility also includes maintenance of adequate
accounting records in accordance with the provisions
of the Act for safeguarding of the assets of the
Company and for preventing and detecting frauds
and other irregularities; selection and application of
appropriate accounting policies; making judgments
and estimates that are reasonable and prudent;
and design, implementation and maintenance
of adequate internal financial controls, that were
operating effectively for ensuring the accuracy and
completeness of the accounting records, relevant to
the preparation and presentation of the standalone
financial statements that give a true and fair view and
are free from material misstatement, whether due to
fraud or error.

In preparing the standalone financial statements, the
Management and Board of Directors are responsible
for assessing the Company's ability to continue as
a going concern, disclosing, as applicable, matters
related to going concern and using the going concern
basis of accounting unless the Board of Directors
either intends to liquidate the Company or to cease
operations, or has no realistic alternative but to do so.

The Board of Directors is also responsible for overseeing
the Company's financial reporting process.

Auditor's Responsibilities for the Audit of the
Standalone Financial Statements

Our objectives are to obtain reasonable assurance
about whether the standalone financial statements as
a whole are free from material misstatement, whether
due to fraud or error, and to issue an auditor's report
that includes our opinion. Reasonable assurance
is a high level of assurance, but is not a guarantee
that an audit conducted in accordance with SAs will
always detect a material misstatement when it exists.
Misstatements can arise from fraud or error and are
considered material if, individually or in the aggregate,
they could reasonably be expected to influence the
economic decisions of users taken on the basis of
these standalone financial statements.

As part of an audit in accordance with SAs, we exercise
professional judgment and maintain professional
skepticism throughout the audit. We also:

» Identify and assess the risks of material misstatement
of the standalone financial statements, whether
due to fraud or error, design and perform audit
procedures responsive to those risks, and obtain
audit evidence that is sufficient and appropriate
to provide a basis for our opinion. The risk of not
detecting a material misstatement resulting from
fraud is higher than for one resulting from error,
as fraud may involve collusion, forgery, intentional
omissions, misrepresentations, or the override of
internal control.

» Obtain an understanding of internal control relevant
to the audit in order to design audit procedures that
are appropriate in the circumstances. Under Section
143(3)(i) of the Act, we are also responsible for
expressing our opinion on whether the company has
adequate internal financial controls with reference
to financial statements in place and the operating
effectiveness of such controls.

» Evaluate the appropriateness of accounting policies
used and the reasonableness of accounting
estimates and related disclosures made by the
Management and Board of Directors.

» Conclude on the appropriateness of the
Management and Board of Directors use of the
going concern basis of accounting in preparation
of standalone financial statements and, based on
the audit evidence obtained, whether a material
uncertainty exists related to events or conditions
that may cast significant doubt on the Company's
ability to continue as a going concern. If we
conclude that a material uncertainty exists, we are
required to draw attention in our auditor's report to
the related disclosures in the standalone financial
statements or, if such disclosures are inadequate, to
modify our opinion. Our conclusions are based on

the audit evidence obtained up to the date of our
auditor's report. However, future events or conditions
may cause the Company to cease to continue as
a going concern.

» Evaluate the overall presentation, structure and
content of the standalone financial statements,
including the disclosures, and whether the
standalone financial statements represent the
underlying transactions and events in a manner that
achieves fair presentation.

We communicate with those charged with governance
regarding, among other matters, the planned scope
and timing of the audit and significant audit findings,
including any significant deficiencies in internal control
that we identify during our audit.

We also provide those charged with governance with
a statement that we have complied with relevant
ethical requirements regarding independence, and
to communicate with them all relationships and
other matters that may reasonably be thought to
bear on our independence, and where applicable,
related safeguards.

From the matters communicated with those charged
with governance, we determine those matters that
were of most significance in the audit of the standalone
financial statements of the current period and are
therefore the key audit matters. We describe these
matters in our auditor's report unless law or regulation
precludes public disclosure about the matter or when,
in extremely rare circumstances, we determine that
a matter should not be communicated in our report
because the adverse consequences of doing so
would reasonably be expected to outweigh the public
interest benefits of such communication.

Report on Other Legal and Regulatory
Requirements

1. As required by the Companies (Auditor's Report)
Order, 2020 (“the Order") issued by the Central
Government of India in terms of Section 143(11)
of the Act, we give in the “Annexure A" a statement
on the matters specified in paragraphs 3 and 4 of
the Order, to the extent applicable.

2 A. As required by Section 143(3) of the Act, we
report that:

a. We have sought and obtained all the
information and explanations which to
the best of our knowledge and belief
were necessary for the purposes of
our audit.

b. In our opinion, proper books of account
as required by law have been kept by
the Company so far as it appears from
our examination of those books except
for the matter stated in the paragraph
2B(f) below on reporting under Rule 11(g)

of the Companies (Audit and Auditors)
Rules, 2014.

c. The standalone balance sheet, the
standalone statement of profit and loss
(including other comprehensive income),
the standalone statement of changes in
equity and the standalone statement of
cash flows dealt with by this Report are
in agreement with the books of account.

d. In our opinion, the aforesaid standalone
financial statements comply with the
Ind AS specified under Section 133 of
the Act.

e. On the basis of the written
representations received from the
directors as on 1 April 2025 taken on
record by the Board of Directors, none
of the directors is disqualified as on 31
March 2025 from being appointed as
a director in terms of Section 164(2) of
the Act.

f. the modification relating to the
maintenance of accounts and other
matters connected therewith are as
stated in the paragraph 2A(b) above
on reporting under Section 143(3)
(b) of the Act and paragraph 2B(f)
below on reporting under Rule 11(g)
of the Companies (Audit and Auditors)
Rules, 2014.

g. With respect to the adequacy of the
internal financial controls with reference
to financial statements of the Company
and the operating effectiveness of such
controls, refer to our separate Report in
“Annexure B".

B. With respect to the other matters to be
included in the Auditor's Report in accordance
with Rule 11 of the Companies (Audit and
Auditors) Rules, 2014, in our opinion and to
the best of our information and according to
the explanations given to us:

a. The Company has disclosed the
impact of pending litigations as at 31
March 2025 on its financial position in
its standalone financial statements
- Refer Note 52 to the standalone
financial statements.

b. The Company did not have any long¬
term contracts including derivative
contracts for which there were any
material foreseeable losses.

c. There has been no delay in transferring
amounts, required to be transferred, to
the Investor Education and Protection
Fund by the Company.

d. (i) The management has represented

that, to the best of its knowledge
and belief, as disclosed in the
Note 60A to the standalone
financial statements, no funds
have been advanced or loaned
or invested (either from borrowed
funds or share premium or any
other sources or kind of funds) by
the Company to or in any other
person(s) or entity(ies), including
foreign entities (“Intermediaries"),
with the understanding, whether
recorded in writing or otherwise,
that the Intermediary shall directly
or indirectly lend or invest in other
persons or entities identified in
any manner whatsoever by or on
behalf of the Company (“Ultimate
Beneficiaries") or provide any
guarantee, security or the like on
behalf of the Ultimate Beneficiaries.

(ii) The management has represented
that, to the best of its knowledge
and belief, as disclosed in the Note
60B to the standalone financial
statements, no funds have been
received by the Company from any
person(s) or entity(ies), including
foreign entities (“Funding Parties"),
with the understanding, whether
recorded in writing or otherwise,
that the Company shall directly
or indirectly, lend or invest in other
persons or entities identified in any
manner whatsoever by or on behalf
of the Funding Parties (“Ultimate
Beneficiaries") or provide any
guarantee, security or the like on
behalf of the Ultimate Beneficiaries.

(iii) Based on the audit procedures
that have been considered
reasonable and appropriate
in the circumstances, nothing
has come to our notice that has
caused us to believe that the
representations under sub-clause
(i) and (ii) of Rule 11(e), as provided
under (i) and (ii) above, contain any
material misstatement.

e. The interim dividend declared and paid

by the Company during the year and

until the date of this audit report is in
accordance with Section 123 of the Act.

f. Based on our examination which included
test checks, the Company has used an
accounting software for maintaining its
books of account which has a feature
of audit trail (edit log) facility and the
same has operated throughout the year
for all relevant transactions recorded in
the software except that the audit trail
was not enabled (i) at the database
level to log any direct data changes;
(ii) at the application level for two fields
relating to production and inventory
and (iii) for certain direct changes at the
application level which were performed
by users having privileged access rights.
Further, where audit trail (edit log) facility
was enabled and operated throughout
the year, we did not come across any
instance of audit trail feature being
tampered with. Additionally, except
where the audit trail was not enabled
in the prior year, the audit trail has
been preserved by the Company as
per the statutory requirements for
record retention.

C. With respect to the matter to be included in
the Auditor's Report under Section 197(16) of
the Act:

In our opinion and according to the
information and explanations given to us,
the remuneration paid by the Company
to its directors during the current year is in
accordance with the provisions of Section
197 of the Act. The remuneration paid to any
director is not in excess of the limit laid down
under Section 197 of the Act. The Ministry of
Corporate Affairs has not prescribed other
details under Section 197(16) of the Act which
are required to be commented upon by us.

For B S R & Co. LLP

Chartered Accountants
Firm's Registration No.:101248W/W-100022

Rekha Shenoy

Partner

Place: Mumbai Membership No.: 124219

Date: 30 April 2025 ICAI UDIN: 25124219BMOOVM6838

 
STOCKS A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z|Others

Mutual Fund A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others

SEBI Registration No's: NSE / BSE / MCX : INZ000166638. Depository Participant: IN- DP-224-2016.
AMFI Registered Number - 29900 (ARN valid upto 24th July 2025) - AMFI-Registered Mutual Fund Distributor since June 2008.
Compliance Officer :- Name: Ch.V.A. Varaprasad, Mobile No.: 9393136201, E-mail: varaprasad.challa@rlpsec.com
Grievance Cell: rlpsec_grievancecell@yahoo.com , rlpdp_grievancecell@yahoo.com
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.
Copyrights @ 2014 © RLP Securities. All Right Reserved Designed, developed and content provided by